Overview
Yujia Wang practices in Tianjin, China. Wang is highly rated in 2 conditions, according to our data. Their top areas of expertise are Lacrimal Gland Tumor, Large-Cell Immunoblastic Lymphoma, Splenic Neoplasm, Mantle Cell Lymphoma (MCL), and Splenectomy.
Their clinical research consists of co-authoring 28 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lacrimal Gland TumorWang isAdvanced. Learn about Lacrimal Gland Tumor.
- Large-Cell Immunoblastic Lymphoma
- Experienced
- B-Cell LymphomaWang isExperienced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Follicular LymphomaWang isExperienced. Learn about Follicular Lymphoma.
- Hairy Cell Leukemia (HCL)Wang isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Mantle Cell Lymphoma (MCL)Wang isExperienced. Learn about Mantle Cell Lymphoma (MCL).